1-4 of 4
Doris Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Analytical Validation of Patient-Specific PCR-Based MRD Assessment for Use As a Primary Endpoint in CLL Clinical Trials

Anke Schilhabel, Henrik Knecht, Anton W. Langerak, Jacques J.M. van Dongen, Michael Kneba, Jill Ray, Elizabeth Punnoose, Doris Kim, Thomas Haberberger, Coen Bernaards, Yuda Zhu, Sock-Cheng Lewin-Koh, Matthias Ritgen
Journal: Blood
Blood (2015) 126 (23): 2924.
https://doi.org/10.1182/blood.V126.23.2924.2924
Published: 2015
Journal Articles

Kras G12D Expression in Hematopoietic Stem/Progenitor Cells Initiates T Cell Acute Lymphoblastic Leukemia/Lymphoma.

Monique Dail, PhD, Qing Li, MD, PhD, Jennifer Lauchle, MD, Andrew McDaniel, Doris Kim, Keiko Akagi, PhD, Linda Wolff, PhD, Nancy Jenkins, PhD, Neil Copeland, PhD, Kevin Shannon, MD
Journal: Blood
Blood (2007) 110 (11): 153.
https://doi.org/10.1182/blood.V110.11.153.153
Published: 2007
Journal Articles

Mutations That Cooperate with Nf1 Inactivation in Leukemogenesis Influence Therapeutic Response to MEK Inhibition.

Jennifer O. Lauchle, MD, Doan T. Le, MD, Doris Kim, Keiko Akagi, PhD, Matthew F. Gorman, MD, Mary Tran, Judith Sebolt-Leopold, PhD, Linda Wolff, PhD, Luis F. Parada, PhD, Nancy Jenkins, PhD, Neal Copeland, PhD, Kevin M. Shannon, MD
Journal: Blood
Blood (2007) 110 (11): 594.
https://doi.org/10.1182/blood.V110.11.594.594
Published: 2007
Journal Articles

Disease Stage Strongly Modulates Responsiveness to Targeted Agents in Nf1 Mutant Mice with Myeloprolfierative Disease (MPD) and Acute Myeloid Leukemia (AML).

Jennifer O. Lauchle, MD, Doan Le, MD, Doris Kim, BA, Mary Tran, BA, Abigail Peterson, BA, Sally Przybranowski, PhD, Luis Parada, PhD, Linda Wolff, PhD, Judith Leopold, PhD, Kevin M. Shannon, MD
Journal: Blood
Blood (2005) 106 (11): 496.
https://doi.org/10.1182/blood.V106.11.496.496
Published: 2005